Hideki Terashima
Kobe, 6500047, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Enhancement of chloride transport via Ca2+ mobilization in airway epithelial cells by DS-1039, a novel selective GPR39 agonist.
Journal: European journal of pharmacology
Published: May 23, 2025
Discovery of DS79932728: A Potent, Orally Available G9a/GLP Inhibitor for Treating β-Thalassemia and Sickle Cell Disease.
Journal: ACS medicinal chemistry letters
Published: October 28, 2020
Design, synthesis, and optimization of a series of 2-azaspiro[3.3]heptane derivatives as orally bioavailable fetal hemoglobin inducers.
Journal: Bioorganic & medicinal chemistry letters
Published: May 30, 2020
Phenotypic-screening generates active novel fetal globin-inducers that downregulate Bcl11a in a monkey model.
Journal: Biochemical pharmacology
Published: October 10, 2019
Perturbation-Based Proteomic Correlation Profiling as a Target Deconvolution Methodology.
Journal: Cell chemical biology
Published: May 08, 2018
Attenuation of pulmonary fibrosis in type I collagen-targeted reporter mice with ALK-5 inhibitors.
Journal: Pulmonary pharmacology & therapeutics
Published: April 16, 2018
R-268712, an orally active transforming growth factor-β type I receptor inhibitor, prevents glomerular sclerosis in a Thy1 nephritis model.
Journal: European journal of pharmacology
Published: September 09, 2013
A novel inhibitor of stearoyl-CoA desaturase-1 attenuates hepatic lipid accumulation, liver injury and inflammation in model of nonalcoholic steatohepatitis.
Journal: Biological & pharmaceutical bulletin
Published: February 02, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026